Time to First Cardiovascular Hospitalization*7
Survival Probability
Months From First Dose
Pooled Tafamidis
Placebo
Hazard ratio, 0.795 (95% CI, 0.616-1.026)
0.0
0.2
0.4
0.6
0.8
1.0
0
3
6
9
12
15
18
21
24
27
30
33
No. at Risk
Patients Remaining at Risk
(Cumulative Events)
|
||||||||||||||||||||||||||
|
*Post hoc analysis.
CV: cardiovascular.
